Study: Antidepressant warnings prompt caution, not panic

01/7/2008 | NYTimes.com

FDA warning labels on the risk of suicide linked to antidepressants appear to inspire caution, not panic, in young patients, a report published this week says. The study focused on prescription rates from three time periods, including the year after the FDA pushed for the stronger warnings.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT